Endoscopic and minimally invasive devices. GI stents, biopsy forceps, and EMR/ESD products. Global leader in endoscopic accessories.

Structural heart disease company. TAVR (transcatheter aortic valve replacement) devices. China's leading TAVR manufacturer.

Next-gen ADC (antibody-drug conjugate) platform. Multiple ADC candidates in clinical trials. Partnership with BioNTech for $1.5B+.

Bispecific antibody and ADC platform. KN046 (PD-L1/CTLA-4 bispecific) and KN026 (HER2 bispecific) in clinical trials.

Oncology-focused biotech. Fruquintinib approved in US and China. Savolitinib for lung cancer. Partnership with AstraZeneca.

Rare disease and specialty pharma. Licensed drugs from BioMarin, Apogenix. Focus on genetic diseases and oncology.

Innovative drug company with focus on oncology and CNS. Partnership with Merck, Gilead. AI-powered drug discovery platform.

Large pharma transitioning to innovative drugs. NBP (neuroprotectant) and oncology pipeline. mRNA technology platform.

Specialty pharma with innovative drug platform. Microspheres, liposomes, and other advanced drug delivery systems. CNS and oncology focus.

In-licensing and developing innovative drugs for China market. Oncology, autoimmune, and infectious diseases. Partnership with GSK, Regeneron.